These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22066296)

  • 1. Soaps and germicides as adjunct topical antimycotic agents on candida species implicated in vulvovaginal candidasis.
    Ogunshe AA; Omotoso OA; Akindele TM
    East Afr J Public Health; 2011 Jun; 8(2):112-8. PubMed ID: 22066296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
    Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
    Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing chemical germicides against Candida species using quantitative carrier and fingerpad methods.
    Traoré O; Springthorpe VS; Sattar SA
    J Hosp Infect; 2002 Jan; 50(1):66-75. PubMed ID: 11825054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women.
    Verghese S; Padmaja P; Asha M; Elizabeth SJ; Anitha A; Kundavi KM; Jayanthi N; Varma T
    Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of antiseptics and disinfectants versus clinical isolates of Candida species.
    Silverman J; Vazquez JA; Sobel JD; Zervos MJ
    Infect Control Hosp Epidemiol; 1999 Oct; 20(10):676-84. PubMed ID: 10530645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
    Abu-Elteen KH
    Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic and clinical characteristics of mycotic vaginitis caused by Candida glabrata (Torulopsis glabrata)].
    Pawlik B; Liber Z; Warzyńska R
    Med Dosw Mikrobiol; 1989; 41(3-4):206-14. PubMed ID: 2701236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
    Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory activity of vaginal Lactobacillus bacteria on yeasts causing vulvovaginal candidiasis].
    Strus M; Brzychczy-Włoch M; Kucharska A; Gosiewski T; Heczko PB
    Med Dosw Mikrobiol; 2005; 57(1):7-17. PubMed ID: 16130291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis.
    Friese K; Neumann G; Siebert J
    Arch Gynecol Obstet; 2003 Aug; 268(3):194-7. PubMed ID: 12942250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of Candida kefyr (C. pseudotropicalis) in reproductive tract infections].
    Pawlik B; Jodłowska V
    Med Dosw Mikrobiol; 1992; 44(1-2):83-8. PubMed ID: 1297040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.
    Redondo-Lopez V; Lynch M; Schmitt C; Cook R; Sobel JD
    Obstet Gynecol; 1990 Oct; 76(4):651-5. PubMed ID: 2216197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].
    Kurnatowska AK; Kwaśniewska J
    Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on Candida no-albicans species and its relation to recurrent vulvovaginal candidiasis].
    Buitrón García R; Romero Cabello R; Cruz Talonia F; Bonifaz A; Zarama Marquez F
    Ginecol Obstet Mex; 2002 Sep; 70():431-6. PubMed ID: 12448051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women.
    al-Rawi N; Kavanagh K
    Br J Biomed Sci; 1999; 56(2):99-104. PubMed ID: 10695049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status.
    Goswami R; Dadhwal V; Tejaswi S; Datta K; Paul A; Haricharan RN; Banerjee U; Kochupillai NP
    J Infect; 2000 Sep; 41(2):162-6. PubMed ID: 11023762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.